Simon A Mahler1, Jason P Stopyra2, Fred S Apple3, Robert F Riley4, Gregory B Russell5, Brian C Hiestand2, James W Hoekstra2, Cedric W Lefebvre2, Bret A Nicks2, David M Cline2, Kim L Askew2, David M Herrington6, Gregory L Burke5, Chadwick D Miller2. 1. Department of Emergency Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: smahler@wakehealth.edu. 2. Department of Emergency Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA. 3. Department Laboratory Medicine and Pathology, Hennepin County Medical Center and University of Minnesota Medical School, Minneapolis, MN, USA. 4. Division of Cardiology, University of Washington, Seattle, WA, USA. 5. Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA. 6. Department of Internal Medicine, Division of Cardiology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Abstract
OBJECTIVES: The HEART Pathway combines a decision aid and serial contemporary cardiac troponin I (cTnI) measures to achieve >99% sensitivity for major adverse cardiac events (MACE) at 30days and early discharge rates >20%. However, the impact of integrating high-sensitivity troponin (hs-cTn) measures into the HEART Pathway has yet to be determined. In this analysis we compare test characteristics of the HEART Pathway using hs-cTnI, hs-cTnT, or cTnI. DESIGN & METHODS: A secondary analysis of participants enrolled in the HEART Pathway RCT was conducted. Each patient was risk stratified by the cTn-HEART Pathway (Siemens TnI-Ultra at 0- and 3-h) and a hs-cTn-HEART Pathway using hs-cTnI (Abbott) or hs-cTnT (Roche) at 3-h. The early discharge rate, sensitivity, specificity, and negative predictive value (NPV) for MACE (death, myocardial infarction, or coronary revascularization) at 30days were calculated. RESULTS: hs-cTnI measures were available on 133 patients. MACE occurred in 11/133 (8%) of these patients. Test characteristics for the HEART Pathway using serial cTnI vs 3hour hs-cTnI were the same: sensitivity (100%, 95%CI: 72-100%), specificity (49%, 95%CI: 40-58%), NPV (100%, 95%CI: 94-100%), and early discharge rate (45%, 95%CI: 37-54%). The HEART Pathway using hs-cTnT missed one MACE event (myocardial infarction): sensitivity (91%, 95%CI: 59-100%), specificity (48%, 95%CI: 39-57%), NPV (98%, 95%CI: 91-100%), and early discharge rate (45%, 95%CI: 37-54%). CONCLUSIONS: There was no difference in the test characteristics of the HEART Pathway whether using cTnI or hs-cTnI, with both achieving 100% sensitivity and NPV. Use of hs-cTnT with the HEART Pathway was associated with one missed MACE.
RCT Entities:
OBJECTIVES: The HEART Pathway combines a decision aid and serial contemporary cardiac troponin I (cTnI) measures to achieve >99% sensitivity for major adverse cardiac events (MACE) at 30days and early discharge rates >20%. However, the impact of integrating high-sensitivity troponin (hs-cTn) measures into the HEART Pathway has yet to be determined. In this analysis we compare test characteristics of the HEART Pathway using hs-cTnI, hs-cTnT, or cTnI. DESIGN & METHODS: A secondary analysis of participants enrolled in the HEART Pathway RCT was conducted. Each patient was risk stratified by the cTn-HEART Pathway (Siemens TnI-Ultra at 0- and 3-h) and a hs-cTn-HEART Pathway using hs-cTnI (Abbott) or hs-cTnT (Roche) at 3-h. The early discharge rate, sensitivity, specificity, and negative predictive value (NPV) for MACE (death, myocardial infarction, or coronary revascularization) at 30days were calculated. RESULTS: hs-cTnI measures were available on 133 patients. MACE occurred in 11/133 (8%) of these patients. Test characteristics for the HEART Pathway using serial cTnI vs 3hour hs-cTnI were the same: sensitivity (100%, 95%CI: 72-100%), specificity (49%, 95%CI: 40-58%), NPV (100%, 95%CI: 94-100%), and early discharge rate (45%, 95%CI: 37-54%). The HEART Pathway using hs-cTnT missed one MACE event (myocardial infarction): sensitivity (91%, 95%CI: 59-100%), specificity (48%, 95%CI: 39-57%), NPV (98%, 95%CI: 91-100%), and early discharge rate (45%, 95%CI: 37-54%). CONCLUSIONS: There was no difference in the test characteristics of the HEART Pathway whether using cTnI or hs-cTnI, with both achieving 100% sensitivity and NPV. Use of hs-cTnT with the HEART Pathway was associated with one missed MACE.
Authors: C P Cannon; A Battler; R G Brindis; J L Cox; S G Ellis; N R Every; J T Flaherty; R A Harrington; H M Krumholz; M L Simoons; F J Van De Werf; W S Weintraub; K R Mitchell; S L Morrisson; R G Brindis; H V Anderson; D S Cannom; W R Chitwood; J E Cigarroa; R L Collins-Nakai; S G Ellis; R J Gibbons; F L Grover; P A Heidenreich; B K Khandheria; S B Knoebel; H L Krumholz; D J Malenka; D B Mark; C R Mckay; E R Passamani; M J Radford; R N Riner; J B Schwartz; R E Shaw; R J Shemin; D B Van Fossen; E D Verrier; M W Watkins; D R Phoubandith; T Furnelli Journal: J Am Coll Cardiol Date: 2001-12 Impact factor: 24.094
Authors: Johannes Tobias Neumann; Nils Arne Sörensen; Tjark Schwemer; Francisco Ojeda; Rafael Bourry; Vanessa Sciacca; Sarina Schaefer; Christoph Waldeyer; Christoph Sinning; Thomas Renné; Martin Than; William Parsonage; Karin Wildi; Nataliya Makarova; Renate B Schnabel; Ulf Landmesser; Christian Mueller; Louise Cullen; Jaimi Greenslade; Tanja Zeller; Stefan Blankenberg; Mahir Karakas; Dirk Westermann Journal: JAMA Cardiol Date: 2016-07-01 Impact factor: 14.676
Authors: A Jacob Six; Louise Cullen; Barbra E Backus; Jaimi Greenslade; William Parsonage; Sally Aldous; Pieter A Doevendans; Martin Than Journal: Crit Pathw Cardiol Date: 2013-09
Authors: Simon A Mahler; Chadwick D Miller; Judd E Hollander; John T Nagurney; Robert Birkhahn; Adam J Singer; Nathan I Shapiro; Ted Glynn; Richard Nowak; Basmah Safdar; Mary Peberdy; Francis L Counselman; Abhinav Chandra; Joshua Kosowsky; James Neuenschwander; Jon W Schrock; Stephen Plantholt; Deborah B Diercks; W Frank Peacock Journal: Int J Cardiol Date: 2012-10-30 Impact factor: 4.164
Authors: Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Hugo A Katus; Bertil Lindahl; David A Morrow; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Robert O Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasché; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; José-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis Journal: Circulation Date: 2012-08-24 Impact factor: 29.690
Authors: Fred S Apple; Allan S Jaffe; Paul Collinson; Martin Mockel; Jordi Ordonez-Llanos; Bertil Lindahl; Judd Hollander; Mario Plebani; Martin Than; M H M Chan Journal: Clin Biochem Date: 2014-09-07 Impact factor: 3.281
Authors: Tobias Reichlin; Louise Cullen; William A Parsonage; Jaimi Greenslade; Raphael Twerenbold; Berit Moehring; Karin Wildi; Sandra Mueller; Christa Zellweger; Tamina Mosimann; Maria Rubini Gimenez; Katharina Rentsch; Stefan Osswald; Christian Müller Journal: Am J Med Date: 2014-11-13 Impact factor: 4.965
Authors: Sally Aldous; A Mark Richards; Peter M George; Louise Cullen; William A Parsonage; Dylan Flaws; Christopher M Florkowski; Richard W Troughton; Jack W O'Sullivan; Christopher M Reid; Laura Bannister; Martin Than Journal: Int J Cardiol Date: 2014-09-28 Impact factor: 4.164
Authors: Laura Sarkisian; Lotte Saaby; Tina S Poulsen; Oke Gerke; Nikolaj Jangaard; Susanne Hosbond; Axel C P Diederichsen; Kristian Thygesen; Hans Mickley Journal: Am J Med Date: 2015-12-01 Impact factor: 4.965
Authors: Edward Hyun Suh; Aleksandr M Tichter; Lauren S Ranard; Andrew Amaranto; Betty C Chang; Phong Anh Huynh; Alexander Kratz; Rebekah Jihae Lee; LeRoy E Rabbani; Dana Sacco; Andrew J Einstein Journal: J Am Coll Emerg Physicians Open Date: 2022-05-05
Authors: Anna C Snavely; Nella Hendley; Jason P Stopyra; Kristin M Lenoir; Brian J Wells; David M Herrington; Brian C Hiestand; Chadwick D Miller; Simon A Mahler Journal: Am Heart J Date: 2020-11-06 Impact factor: 4.749
Authors: Nicklaus P Ashburn; Zachary P Smith; Kale J Hunter; Nella W Hendley; Simon A Mahler; Brian C Hiestand; Jason P Stopyra Journal: Am J Emerg Med Date: 2020-08-15 Impact factor: 4.093
Authors: Gerald J Kost; Amanullah Zadran; Thuan T B Duong; Tung T Pham; An V D Ho; Nhan V Nguyen; Irene J Ventura; Layma Zadran; Mykhaylo V Sayenko; Kelly Nguyen Journal: Point Care Date: 2018-08-27